Living Cell Technologies Enters Pig Tissue Services Deal for NTCELL Clinical Trial
03:06 AM EST, 01/24/2022 (MT Newswires) -- Living Cell Technologies (ASX:LCT) entered a services agreement with New Zealand biotechnology company NZeno. Under the agreement, NZeno will breed and main
MT NewswiresJan 24, 2022 03:10 ET
Living Cell Technologies Secures Nearly $3 Million in Funding for Parkinson's Disease Treatment
06:21 AM EDT, 10/20/2021 (MT Newswires) -- Living Cell Technologies (ASX:LCT) has secured funding for the third clinical trial of NTCELL in Parkinson's disease, according to a Tuesday filing. The Au
MT NewswiresOct 20, 2021 06:26 ET
Sydney Most Actives
Volume Close Change % Change Metals Australia 149,965,556 0.002 unch unch YPB Group 8
Dow Jones NewswiresOct 20, 2021 03:10 ET
BRIEF-Living Cell Technologies Secures Funding For Third Clinical Trial Of NTCELL In Parkinson's Disease
Oct 19 (Reuters) - Living Cell Technologies Ltd LCT.AX :* SECURED FUNDING FOR A THIRD CLINICAL TRIAL OF NTCELL IN PARKINSON'S DISEASE* COMPLETED PLACEMENT RAISING A$3.5 MILLIONSource text for Eikon:
reutersOct 18, 2021 20:56 ET
No Data
No Data